AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.35
Delayed Data
As of Apr 25
 0.00 / 0.00%
Today’s Change
1.55
Today|||52-Week Range
5.75
+16.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues5.2M19.3M17.4M8.0M
 
 
 
 
 
Cost of Goods Sold--778.0K10.3M8.9M
 
 
 
 
Depreciation And Amortization866.0K2.0M2.1M1.7M
 
 
 
 
 
 
Operating ExpensesGross Income--16.5M5.0M-2.7M
 
 
 
 
General Expenses42.0M35.7M37.0M36.0M
 
 
 
 
 
Research And Development24.5M22.5M21.4M19.4M
 
 
 
 
 
Total Operating Expenses42.9M38.5M49.3M46.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-37.6M-19.2M-32.0M-38.7M
 
 
 
 
 
Extraordinary Credit7.6M2.1M600.0K95.0K
 
 
 
 
 
Extraordinary Charge0.00-756.0K0.000.00
 
 
Interest Expense On Debt2.6M5.4M12.2M14.0M
 
 
 
 
 
Other Expenses-651.0K-380.0K318.0K415.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.4M-23.6M-43.2M-52.2M
 
 
 
 
 
Income Taxes0.00-760.0K-34.0K-701.0K
 
 
 
 
Net Income-33.4M-24.4M-43.2M-51.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.4M44.3M45.3M46.9M
 
 
 
 
 
Shares To Calculate EPS Diluted44.3M44.5M45.3M46.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.91-$0.60-$0.95-$1.10
 
 
 
 
 
EPS Diluted-$0.91-$0.60-$0.95-$1.10